Guardant Health to Report Second Quarter Financial Results on August 5, 2021
July 13 2021 - 8:05AM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced it will report financial results for the
second quarter 2021 after market close on Thursday, August 5, 2021.
Company management will be webcasting a corresponding conference
call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern
Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.guardanthealth.com. The
webcast will be archived and available for replay after the
event.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
tests, vast data sets and advanced analytics. The Guardant Health
oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched Guardant360®, Guardant360 CDx,
Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI®
tests for advanced stage cancer patients, and Guardant Reveal™ for
early-stage cancer patients. These tests fuel development of its
LUNAR screening program, which aims to address the needs of
asymptomatic individuals eligible for cancer screening.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210713005243/en/
Investor Contact: Carrie Mendivil
investors@guardanthealth.com
Media Contact: Anna Czene press@guardanthealth.com
Julie Johnson julie.johnson@uncappedcommunications.com
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Apr 2023 to Apr 2024